Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet - a population-based study.
LANCET July 2017
Annually rare cancer diagnoses in Europe represent about 22% of all cancer cases diagnosed. RARECARE
![events](/rarecarenet/images/homepage/events.png)
No events |
![news](/rarecarenet/images/homepage/news.png)
![Rare Cancer Patient](/rarecarenet/images/homepage/quote2.png)
![slides](/rarecarenet/images/homepage/slides.png)